USD
+$0.00
(+0.00%
)At Close (As of Sep 3, 2025)
$587.27M
Market Cap
-
P/E Ratio
-2.03
EPS
$8.98
52 Week High
$3.86
52 Week Low
LIFE SCIENCES
Sector
Field | Value (USD) |
---|---|
Gross Profit | $9.5M |
Total Revenue | $33M |
Cost Of Revenue | $24M |
Costof Goods And Services Sold | $24M |
Operating Income | -$164M |
Selling General And Administrative | $54M |
Research And Development | $119M |
Operating Expenses | $174M |
Investment Income Net | - |
Net Interest Income | -$9.1M |
Interest Income | $4.1M |
Interest Expense | $13M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $13M |
Income Before Tax | -$148M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$148M |
Comprehensive Income Net Of Tax | - |
Ebit | -$135M |
Ebitda | -$122M |
Net Income | -$148M |
Field | Value (USD) |
---|---|
Total Assets | $270M |
Total Current Assets | $124M |
Cash And Cash Equivalents At Carrying Value | $104M |
Cash And Short Term Investments | $104M |
Inventory | $385K |
Current Net Receivables | $11M |
Total Non Current Assets | $146M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $821K |
Intangible Assets Excluding Goodwill | $821K |
Goodwill | - |
Investments | - |
Long Term Investments | $6.7M |
Short Term Investments | - |
Other Current Assets | $8.8M |
Other Non Current Assets | - |
Total Liabilities | $202M |
Total Current Liabilities | $61M |
Current Accounts Payable | $24M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $8.1M |
Total Non Current Liabilities | $141M |
Capital Lease Obligations | $12M |
Long Term Debt | $73M |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $85M |
Other Current Liabilities | $24M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $68M |
Treasury Stock | - |
Retained Earnings | -$702M |
Common Stock | $3K |
Common Stock Shares Outstanding | $70M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$104M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $13M |
Capital Expenditures | $5M |
Change In Receivables | - |
Change In Inventory | -$387K |
Profit Loss | - |
Cashflow From Investment | $23M |
Cashflow From Financing | $55M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$148M |
Field | Value (USD) |
---|---|
Gross Profit | $9.5M |
Total Revenue | $33M |
Cost Of Revenue | $24M |
Costof Goods And Services Sold | $24M |
Operating Income | -$164M |
Selling General And Administrative | $54M |
Research And Development | $119M |
Operating Expenses | $174M |
Investment Income Net | - |
Net Interest Income | -$9.1M |
Interest Income | $4.1M |
Interest Expense | $13M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $13M |
Income Before Tax | -$148M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$148M |
Comprehensive Income Net Of Tax | - |
Ebit | -$135M |
Ebitda | -$122M |
Net Income | -$148M |
Sector: LIFE SCIENCES
Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
MeiraGTx Holdings plc, a clinical-stage gene therapy company, focused on developing treatments for patients living with serious illnesses. The company is headquartered in New York, New York.